000 01505 a2200421 4500
005 20250517043317.0
264 0 _c20160919
008 201609s 0 0 eng d
022 _a2567-689X
024 7 _a10.1160/TH15-02-0128
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan den Besselaar, A M H P
245 0 0 _aPoint-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist.
_h[electronic resource]
260 _bThrombosis and haemostasis
_cNov 2015
300 _a1260-7 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAcenocoumarol
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aData Accuracy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
_xinstrumentation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPoint-of-Care Testing
650 0 4 _aReproducibility of Results
650 0 4 _aSelf Care
650 0 4 _aVitamin K
_xantagonists & inhibitors
650 0 4 _aWarfarin
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aBiedermann, Joseph S
700 1 _aKruip, Marieke J H A
773 0 _tThrombosis and haemostasis
_gvol. 114
_gno. 6
_gp. 1260-7
856 4 0 _uhttps://doi.org/10.1160/TH15-02-0128
_zAvailable from publisher's website
999 _c25101227
_d25101227